Wild-type transthyretin-related (ATTR) amyloidosis digital illustration

Wild-type transthyretin-related (ATTR) amyloidosis Save


ICD-10 code: E85.82

Disease category: E85.8: Other amyloidosis

Understanding Wild-type Transthyretin-related (ATTR) Amyloidosis

Wild-type transthyretin-related (ATTR) amyloidosis is a rare disease characterized by the buildup of abnormal proteins in various tissues, leading to organ dysfunction. This condition primarily affects older individuals, typically over the age of 60, and predominantly affects males.

Causes:

In wild-type ATTR amyloidosis, the transthyretin protein, which is responsible for transporting thyroid hormone and vitamin A in the body, becomes unstable and forms amyloid fibrils. These fibrils accumulate in organs, such as the heart, kidneys, nerves, and gastrointestinal tract, impairing their normal functioning.

Symptoms:

The symptoms of wild-type ATTR amyloidosis can vary depending on the affected organs. Common symptoms include:

  1. Heart-related symptoms: Shortness of breath, fatigue, irregular heartbeat, and leg swelling.
  2. Neurological symptoms: Numbness, tingling, weakness, and difficulty walking.
  3. Gastrointestinal symptoms: Nausea, diarrhea, and unintentional weight loss.
  4. Kidney-related symptoms: Decreased urine output, swelling in the legs, and increased thirst.

Diagnosis:

Diagnosing wild-type ATTR amyloidosis can be challenging due to its similarity to other diseases. However, several tests can aid in the diagnosis, including:

  1. Biopsy: A small tissue sample is taken from the affected organ to analyze the presence of amyloid fibrils.
  2. Genetic testing: Identifying any genetic mutations associated with ATTR amyloidosis.
  3. Imaging tests: MRI or CT scans can help visualize the organs affected by amyloid deposits.
  4. Blood tests: Measuring the levels of transthyretin and other proteins in the blood.

Management:

While there is no specific treatment for wild-type ATTR amyloidosis at the moment, managing the symptoms and complications is crucial. Patients may benefit from medications targeting specific symptoms, such as heart failure or neuropathy. Regular monitoring of organ function and supportive therapies are also important.

Conclusion:

Wild-type transthyretin-related (ATTR) amyloidosis is a rare disease characterized by the accumulation of abnormal proteins in various organs. Understanding the causes, symptoms, and diagnosis of this condition is essential for early detection and management. If you suspect you or a loved one may be experiencing symptoms related to ATTR amyloidosis, it is important

Treatment of Wild-type transthyretin-related (ATTR) amyloidosis:

Treatment Options for Wild-type Transthyretin-related (ATTR) Amyloidosis

Wild-type Transthyretin-related (ATTR) amyloidosis is a rare disease that affects the heart, causing symptoms such as heart failure and abnormal heart rhythms. Fortunately, there are various treatment options available to manage this condition and improve patients' quality of life.

  1. Medi...

    To see full information about treatment please Sign up or Log in